Neuroimmune Modulation for Inflammatory Disease: Interview with Dr. Simhambhatla, President and CEO of SetPoint Medical
SetPoint Medical, a medtech company based in California, is developing a neuromodulatory device that is intended to treat rheumatoid arthritis. The overlap between the nervous and immune systems is increasingly appreciated, and this technology aims t...
Source: Medgadget - Category: Medical Devices Authors: Conn Hastings Tags: Exclusive Medicine Neurology autoimmune immunology SetPointMed Source Type: blogs
More News: Allergy & Immunology | Arthritis | Autoimmune Disease | Brain | Brain Cancers | Cancer | Cancer & Oncology | Cervical Cancer | Chronic Pain | Clinical Trials | Crohn's Disease | Inflammatory Bowel Disease | Medical Devices | Multiple Sclerosis | Neurology | Pain | Psoriasis | Psoriatic Arthritis | Reflex Sympathetic Dystrophy | Rheumatoid Arthritis | Rheumatology | Study | Ulcerative Colitis | Warnings